Moderna Begins COVID-19 Vaccine Trial for Children Under 12

CAMBRIDGE, Mass.  (WBAP/KLIF News) – Moderna has began it’s COVID-19 vaccine trial for children between the ages of 6 months to 12 years old. In a statement released Tuesday, the biotechnology company, said the first participants have been dosed in the Phase 2/3 study, called the KidCOVE study, of it’s vaccine called mRNA-1273. Scientists are…MORE